Status:
COMPLETED
Safety and Efficacy of Using LEORTEC-300 System For Hair Removal Treatment
Lead Sponsor:
Leortec Medical Systems Ltd
Conditions:
Epilation
Eligibility:
All Genders
18-70 years
Phase:
PHASE1
PHASE2
Brief Summary
Removal of unwanted hair is one of the most commonly sought cosmetic solutions. Traditional methods, such as shaving, depilatories, tweezing and waxing result in only temporary hair removal, and thus ...
Detailed Description
STUDY OBJECTIVES 1. Primary Objective * Safety * To evaluate the safety of using LEORTEC-300 System for hair removal treatment, in different skin/hair colors and anatomical sites. 2. Second...
Eligibility Criteria
Inclusion
- Healthy males/females between the ages of 18 to 70
- Subject is willing to go trough hair removal treatment.
- Subject understands the study procedure.
- Subject is willing to sign the inform consent.
- Subject must have the ability to comply with the study procedures and follow- up.
Exclusion
- Age \< 18 years or \> 70 years.
- Use of medication for which 400nm to 1400nm light exposure is contraindicated
- Coagulation disorder.
- Infection / abscess / pains in treatment target area.
- Recently tanned skin.
- Photosensitivity or allergy.
- Psoriasis.
- Skin cancer.
- Diabetes.
- Pregnancy.
- Tattoo on targeted area.
- History of keloid scarring.
- Use of aspirin or antioxidants
- Eczema or dermatitis.
- Subject is suffering extreme general weakness.
- Subject objects to the study protocol.
- Physician objection.
- Known cognitive or psychiatric disorder
- Participation in any other clinical trial
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
End Date :
September 1 2006
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00348257
Start Date
July 1 2006
End Date
September 1 2006
Last Update
February 28 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Elisha Hospital
Haifa, Israel, 34636